Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma
Clinical trial NCT03410693 · COMPLETED
Trial details
- NCT number
- NCT03410693
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2020-10-27
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.